Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Resources: All

Find a resource
  1. bioinformatics x
  2. nanoparticle x
  3. cwig x
  4. breastcancer x
  1. CWIG_May08th2020_DavidGodlove_Recording

    04 Nov 2020

  2. CWIG_May10th2020_RedHat_Recording

    04 Nov 2020

  3. CWIG_Nov08th2019_Pathos_Doig_Slides

    04 Nov 2020

  4. CWIG_Nov08th2020_PathOS_Recording

    04 Nov 2020

  5. CWIG_Oct09th2020_Tibanna_SooLee_Recording

    04 Nov 2020

  6. CWIG_OCT11th2020_JohannesKoster-Recording

    04 Nov 2020

  7. CWIG_Oct152019_PDCIntegrationSBG_Slides

    04 Nov 2020

  8. CWIG_Sept11th2020_Avi Ma'ayan_Recording

    04 Nov 2020

  9. CWIG_Sept13th2019_McKerrow_IntegratingMultiOmics_Slides

    04 Nov 2020

  10. CWIG_Sept13th2019_SBG_Recording

    04 Nov 2020

  11. Development of natural language processing tools for nanoparticle design

    05 Mar 2019 | Contributor(s): Nastassja Lewinski

    Nano WG February 28, 2019: In this presentation, an introduction to the application of natural language processing techniques to nanotechnology data will be discussed.  Natural language processing tools can aid in the automatic categorization, extraction, and analysis of data from...

  12. Development of Targeted Nanomedicines via Machine Learning Processes

    05 Mar 2019 | Contributor(s): Daniel Heller

    Nano WG February 21, 2019Description: We are using data science to facilitate the development of nanoparticle drugs incorporating kinase inhibitors with diverse chemical structures. Doing this work inspired us to bring together the nanoinformatics community...

  13. Integrated analysis of breast cancer cell lines reveals unique signaling pathways

    16 Sep 2014 | Contributor(s): Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman

    AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...

  14. Integrative Cancer Biology Program Datasets

    26 Apr 2016 | Series | Contributor(s): Jonathan Bistline, Michael Reich

    The NCI-ICBP promotes an integrative/systems approach to the study of cancer biology. The Program encourages scientists to study cancer as a complex biological system. Information gained from these studies are used to build reliable and testable predictive computation models of cancer processes...

  15. LBL ICBP50 integrative genomic data

    13 Nov 2014 | Downloads | Contributor(s): Joe Gray, Jonathan Bistline

    From Joe Gray, Lawrence Berkeley National Laboratory.  There are seventeen (17) files in this study: Affymetrix U133A gene expression data (icbp_u133a.gct) Affymetrix U133A gene expression data (ICBP_U133a.zip) Affymetrix splice junction exon-exon data (ICBP_Junction.zip) Affymetrix...

  16. NCI Alliance for Nanotechnology in Cancer, and caNanoLab: A Data Repository for Cancer Nanomedicines

    27 Nov 2018 | Presentations | Contributor(s): Luisa Russell, Mervi Heiskanen

    Nano WG presentation November15, 2018 NCI Alliance for Nanotechnology in Cancer –Structure–Achievements–Scientific FocuscaNanoLab–Intro to Platform–Data Curation–User Statistics–Future Directions

  17. October 2021 CWIG Webinar Slides - Arun Isaac

    27 Dec 2021 | Downloads | Contributor(s): Alan Zheng

  18. October 2021 CWIG Webinar Slides - Pjotr Prins

    27 Dec 2021 | Downloads | Contributor(s): Alan Zheng

  19. Screening for Small Molecules: Target Discovery Against miRNAs for Breast Cancer Treatment

    18 Aug 2015 | Presentations | Contributor(s): Odemaris Narvaez del Pilar

    Breast cancer is one of the leading causes of cancer related deaths and morbidity among women worldwide. Identifying new targets and developing new therapies is very important in order to improve patient outcomes and minimize this health burden. MicroRNAs, a type of non-coding RNA, are potential...

  20. September 2021 CWIG Webinar Slides - Junjun Zhang

    27 Dec 2021 | Presentations | Contributor(s): Alan Zheng